RC
STJ

RegentAtlantic Capital’s St Jude Medical STJ Stock Holding History

RegentAtlantic Capital’s Portfolio STJ Stock Details STJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-18,066
Closed -$1.45M – 408
2016
Q4 		$1.45M Sell
18,066
-275
-1% -$21.8K 0.14% 155
2016
Q3 		$1.46M Sell
18,341
-295
-2% -$23.8K 0.15% 154
2016
Q2 		$1.45M Sell
18,636
-365
-2% -$26K 0.14% 147
2016
Q1 		$145K Sell
19,001
-813
-4% -$44.3K 0.02% 366
2015
Q4 		$1.22M Sell
19,814
-279
-1% -$17.6K 0.13% 166
2015
Q3 		$1.27M Sell
20,093
-285
-1% -$20.3K 0.12% 164
2015
Q2 		$1.49M Hold
20,378
– – 0.13% 156
2015
Q1 		$1.33M Sell
20,378
-170
-0.8% -$11.3K 0.12% 159
2014
Q4 		$1.34M Sell
20,548
-232
-1% -$14.9K 0.11% 162
2014
Q3 		$1.25M Buy
20,780
+12
+0.1% +$784 0.12% 158
2014
Q2 		$1.44M Hold
20,768
– – 0.13% 149
2014
Q1 		$1.36M Sell
20,768
-725
-3% -$47.2K 0.13% 149
2013
Q4 		$1.33M Sell
21,493
-299
-1% -$17.3K 0.13% 151
2013
Q3 		$1.17M Sell
21,792
-235
-1% -$12.1K 0.13% 150
2013
Q2 		$1M Buy
+22,027
New +$955K 0.12% 151

Other funds holding STJ

FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return
JWA
JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

RegentAtlantic Capital's STJ Position: Q1 2017 in Review

RegentAtlantic Capital sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 18,066 shares — an estimated $1.45M sold.

RegentAtlantic Capital first reported a position in STJ in Q2 2013 and held it in 15 quarters. The position peaked at $1.49M in Q2 2015. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • RegentAtlantic Capital reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • RegentAtlantic Capital sold 18,066 St Jude Medical shares in Q1 2017, an estimated $1.45M.
  • RegentAtlantic Capital first reported a position in St Jude Medical in Q2 2013 and held it in 15 quarters.
  • RegentAtlantic Capital's St Jude Medical position peaked at $1.49M in Q2 2015.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on RegentAtlantic Capital's 13F filing for Q1 2017, filed 12 Apr 2017.